Literature DB >> 21717066

Latent tuberculosis: what the host "sees"?

Hannah P Gideon1, JoAnne L Flynn.   

Abstract

Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis (TB), is the most successful pathogen of mankind and remains a major threat to global health as the leading cause of death due to a bacterial pathogen. Yet 90-95% of those who are infected with MTB remain otherwise healthy. These people are classified as "latently infected," but remain a reservoir from which active TB cases will continue to develop ("reactivation tuberculosis"). Latent infection is defined by the absence of clinical symptoms of TB in addition to a delayed hypersensitivity reaction to the purified protein derivative of MTB used in tuberculin skin test or a T-cell response to MTB-specific antigens. In the absence of reliable control measures for tuberculosis, understanding latent MTB infection and subsequent reactivation is a research priority. This review aims to summarize the recent findings in human and non-human primate models of tuberculosis that have led to new concepts of latent tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21717066      PMCID: PMC3788603          DOI: 10.1007/s12026-011-8229-7

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  106 in total

1.  Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts.

Authors:  S H FEREBEE; F W MOUNT
Journal:  Am Rev Respir Dis       Date:  1962-04

Review 2.  Immunological protection against tuberculosis.

Authors:  Willem A Hanekom; Brian Abel; Thomas J Scriba
Journal:  S Afr Med J       Date:  2007-10

3.  History of tuberculosis.

Authors:  H Herzog
Journal:  Respiration       Date:  1998       Impact factor: 3.580

4.  Long term isoniazid prophylaxis. Controlled trial on INH prophylaxis after recent tuberculin conversion in young adults.

Authors:  G J Veening
Journal:  Bull Int Union Tuberc       Date:  1968-12

5.  Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.

Authors:  A C Hesseling; H Rabie; B J Marais; M Manders; M Lips; H S Schaaf; R P Gie; M F Cotton; P D van Helden; R M Warren; N Beyers
Journal:  Clin Infect Dis       Date:  2006-01-11       Impact factor: 9.079

6.  Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness.

Authors:  B Bourdin Trunz; Pem Fine; C Dye
Journal:  Lancet       Date:  2006-04-08       Impact factor: 79.321

7.  Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study.

Authors:  Toshihiko Hara; Noboru Kosaka; Tsuneo Suzuki; Koichiro Kudo; Hitoshi Niino
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

8.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

9.  HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria.

Authors:  Barbara Kalsdorf; Thomas J Scriba; Kathryn Wood; Cheryl L Day; Keertan Dheda; Rodney Dawson; Willem A Hanekom; Christoph Lange; Robert J Wilkinson
Journal:  Am J Respir Crit Care Med       Date:  2009-09-24       Impact factor: 21.405

10.  Eliminating latent tuberculosis.

Authors:  Douglas B Young; Hannah P Gideon; Robert J Wilkinson
Journal:  Trends Microbiol       Date:  2009-04-16       Impact factor: 17.079

View more
  75 in total

1.  Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infection.

Authors:  Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; JoAnne L Flynn; Denise E Kirschner
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

Review 2.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

Review 3.  Macrophage form, function, and phenotype in mycobacterial infection: lessons from tuberculosis and other diseases.

Authors:  Colleen M McClean; David M Tobin
Journal:  Pathog Dis       Date:  2016-07-10       Impact factor: 3.166

4.  Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts.

Authors:  Michael A Mandell; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

Review 5.  Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines.

Authors:  Raymonde B Bekale; Su-Mari Du Plessis; Nai-Jen Hsu; Jyoti R Sharma; Samantha L Sampson; Muazzam Jacobs; Mervin Meyer; Gene D Morse; Admire Dube
Journal:  Pharm Res       Date:  2018-11-08       Impact factor: 4.200

6.  A multi-scale approach to designing therapeutics for tuberculosis.

Authors:  Jennifer J Linderman; Nicholas A Cilfone; Elsje Pienaar; Chang Gong; Denise E Kirschner
Journal:  Integr Biol (Camb)       Date:  2015-04-30       Impact factor: 2.192

Review 7.  Latent tuberculosis infection: myths, models, and molecular mechanisms.

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

Review 8.  The evolutionary pressures that have molded Mycobacterium tuberculosis into an infectious adjuvant.

Authors:  David G Russell
Journal:  Curr Opin Microbiol       Date:  2013-01-03       Impact factor: 7.934

9.  Two-Year Follow-up Study of Mycobacterium tuberculosis Antigen-Driven IFN-γ Responses and Macrophage sCD14 Levels After Tuberculosis Contact.

Authors:  Magdalena Druszczynska; Marcin Wlodarczyk; Grzegorz Kielnierowski; Malwina Kawka; Wieslawa Rudnicka
Journal:  Indian J Microbiol       Date:  2016-02-23       Impact factor: 2.461

10.  Spontaneous latency in a rabbit model of pulmonary tuberculosis.

Authors:  Selvakumar Subbian; Liana Tsenova; Paul O'Brien; Guibin Yang; Nicole L Kushner; Sven Parsons; Blas Peixoto; Dorothy Fallows; Gilla Kaplan
Journal:  Am J Pathol       Date:  2012-09-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.